Among the proteins showing increased levels of phosphorylation in the KRASG12V sample were MEK and ERK, reflecting the expected activation of the RAS/MEK/ERK pathway upon the presence of the activating G12V-mutation in KRAS in this tumor (Figure 2b). The gene discussed is KRAS; the disease is neoplasm.